Skip to main content
Clinical Trials/NCT06743607
NCT06743607
Not Yet Recruiting
N/A

Spinal Stimulation to Improve Upper Extremity Recovery in the Home (SSTIM UE Recover [SURe])

Craig Hospital1 site in 1 country46 target enrollmentFebruary 2025

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cervical Spinal Cord Injury
Sponsor
Craig Hospital
Enrollment
46
Locations
1
Primary Endpoint
Capabilities of Upper Extremity Questionnaire (CUE-Q)
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this research is to evaluate the safety, feasibility, and tolerability of non-invasive spinal stimulation used in the home and/or community in combination with a functional home exercise program for the upper extremities (arm/hand function) as well as their combined impacts on changes in upper extremity function. The expected duration of participation in this study is about 31-33 hours over a 13-25-week period. Enrollees in this study will be randomly assigned to one of two groups: 1) upper extremity functional task-specific training combined with non-invasive transcutaneous spinal stimulation, or 2) waitlist control, which involves the same intervention, but with a 12-week delayed start. Participants complete initial testing (one time if in group one and three times [at weeks 0, 8, and 12] if in group two), 24 1-hour training sessions (2x/week in home with caregiver/companion support and 1x/week with research team in person or via video conference for 8 weeks), a post-treatment evaluation, and a final evaluation (4 weeks after post-treatment).

Registry
clinicaltrials.gov
Start Date
February 2025
End Date
August 2027
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Candace Tefertiller

Executive Director of Research and Evaluation

Craig Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • History of traumatic SCI
  • Less than 12 months post SCI
  • SCI injury level C1-C8
  • SCI categorized as AIS B-D
  • Have passive range of motion (ROM) within functional limits at wrists, shoulders, and elbows
  • Have caregiver support to attend three in-person sessions and ongoing training at home
  • Have a caregiver who, in the judgment of the research team, is qualified to assist the participant in the safe use of TSS
  • Able to complete in-person training sessions and return to Craig Hospital for assessments
  • Experience no complicating physical or cognitive conditions as determined by their physician that would preclude the safe use of electrical stimulation

Exclusion Criteria

  • Experience unstable chronic cardiac or respiratory complaints
  • Have a recent history of fracture, contractures, or skin pressure injuries that might interfere with the intervention
  • Received Botox injections to the UEs, neck, or hands within the last three months
  • Pregnant, planning to become pregnant, or currently breastfeeding
  • Have breakdown in skin area that will come into contact with electrodes
  • Prior nerve or tendon transfer procedure for the UEs
  • Concurrently are participating in another drug or device trial that may interfere with this study
  • Have an implanted pacemaker, spinal cord stimulator, ventriculoperitoneal shunt, deep brain stimulator, or intrathecal pump
  • In the opinion of the investigators, the study is not safe or appropriate for the participant

Outcomes

Primary Outcomes

Capabilities of Upper Extremity Questionnaire (CUE-Q)

Time Frame: Weeks 0, 8, 12, 21, and 25

The CUE-Q version 2.1 measures functional limitation and perceived difficulty of performing actions with upper extremities in individuals with tetraplegia. The CUE-Q has 32 items; each scored on a 1-to-7-point scale representing self-perceived difficulty with total scores ranging from 32 to 224 (higher scores demonstrating greater UE function) and right and left scores assessed separately

Secondary Outcomes

  • Graded Refined Assessment of Strength, Sensibility, and Prehension (GRASSP)(Weeks 0, 8, 12, 21, and 25)
  • International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)(Weeks 0, 8, 12, 21, and 25)
  • Pinch and Grasp Force(Weeks 0, 8, 12, 21, and 25)
  • Global Rating of Change (GRC)(Weeks 8, 12, 21, and 25)
  • Satisfaction with Treatment Scale(Weeks 8, 12, 21, and 25)
  • Qualitative Questions(Weeks 8 and 21)
  • Canadian Occupational Performance Measure (COPM)(Weeks 0, 8, 12, 21, and 25)
  • International Spinal Cord Injury Quality of Life Basic Data Set (QoL-BDS) Version 2.0(Weeks 0, 8, 12, 21, and 25)
  • International Spinal Cord Injury Pain Basic Data Set (ISCIPBDS) Version 3.0(Weeks 0, 8, 12, 21, and 25)

Study Sites (1)

Loading locations...

Similar Trials